GLPBio

SIKs

SIKs (salt-inducible kinases) are serine/threonine-protein kinase involved in various processes such as cell cycle regulation, gluconeogenesis and lipogenesis and tumor suppression etc.

Products Related to SIKs(12)

  • GC11719 structure
    GC11719HG-9-91-01
    CAS: 1456858-58-4
    Purity: >99.00%

    HG-9-91-01 is a salt-inducible kinases (SIK) inhibitor, inhibited SIK1, SIK2, SIK3 with IC50 values of 0.92nM, 6.5nM and 19.4nM, respectively.

  • GC31645 structure
    GC31645YKL-05-099
    CAS: 1936529-65-5
    Purity: >99.50%

    YKL-05-099 is a highly selective small molecule inhibitor of salt-inducible kinases (SIK1: IC 50 = 10nM; SIK2: IC 50 = 40nM; SIK3: IC 50 = 20nM).

  • GC33070 structure
    GC33070ARN-3236
    CAS: 1613710-01-2
    Purity: >99.50%

    ARN-3236 is a selective salt-inducible kinase 2 (SIK2) inhibitor with an IC 50 of less than 1nM. ARN-3236 also inhibits the activity of SIK1 (IC 50 <21.63nM) and SIK3 (IC 50 <6.63nM).

  • GC37951 structure
    GC37951YKL-06-061
    CAS: 2172617-15-9
    Purity: >99.00%

    YKL-06-061 is a potent, selective, second-generation salt-inducible kinase (SIK) inhibitor with IC50 values of 6.56 nM/1.77 nM/20.5 nM for SIK1/2/3, respectively.

  • GC39148 structure
    GC39148Pterosin B
    CAS: 34175-96-7
    Purity: >99.00%

    Pterosin B, a indanone found in bracken fern (Pteridium aquilinum), is an inhibitor of salt-inducible kinase 3 (Sik3) signaling.

  • GC39195 structure
    GC39195YKL-06-062
    CAS: 2172617-16-0
    Purity: >98.00%

    YKL-06-062 is a second-generation salt-inducible kinase (SIK) inhibitor with an IC50 of 2.12 nM/1.40 nM/2.86 nM, respectively.

  • GC62142 structure
    GC62142WH-4-025
    CAS: 1876463-35-2
    Purity: >98.50%

    WH-4-025 is a Salt-inducible kinase (SIK) inhibitor (WO2016023014 A2).

  • GC62657 structure
    GC62657MRIA9
    CAS: 2750707-05-0
    Purity: >98.00%

    MRIA9 is an ATP-competitive, pan Salt-Inducible kinase (SIK) and PAK2/3 inhibitor, with IC50 values of 516 nM, 180 nM and 127 nM for SIK1, SIK2 and SIK3, respectively.

  • GC69169 structure
    GC69169GLPG3970
    CAS: 2403733-82-2
    Purity: >98%

    GLPG3970 (compound 88) is a novel SIK2/SIK3 inhibitor. GLPG3970 can be used for research on inflammation and autoimmune diseases.

  • GC72915 structure
    GC72915(R)-MRT199665
    Purity: >98.00%

    (R)-MRT199665 is an isomer of MRT199665.

  • GC73750 structure
    GC73750GLPG3312
    CAS: 2340388-72-7
    Purity: >98.00%

    GLPG3312 (Compound 28) is a selective pan-SIK inhibitor with IC50 values of 2.0 nM, 0.7 nM and 0.6 nM for SIK1, SIK2 and SIK3, respectively.

  • GC79425 structure
    GC79425SK-124
    CAS: 2760404-50-8
    Purity: >95.00%

    SK-124 is an orally active salt-inducible kinase ( SIK ) inhibitor with an IC 50 of 230 nM against SIK1, 4.1 nM against SIK2, and 21 nM against SIK3, exhibiting excellent kinome selectivity [1] [2] [4] . SK-124 blocks SIK-mediated CRTC2 phosphorylation, promotes CRTC2 nuclear translocation, and regulates vitamin D metabolism by upregulating renal Cyp27b1 and downregulating Cyp24a1 [1] [4] . SK-124 upregulates the expression of bone-related genes, increases serum Ca 2+, 1,25-vitamin D and intact FGF23 levels, and suppresses endogenous PTH levels [1] [2] [3] [4] . SK-124 can be used in studies related to osteoporosis, male osteoporosis, and chronic kidney disease-mineral and bone disorder [2] [3] [4] .